The Incontinence Skin Care Products Market size is anticipated to grow at a CAGR of 5.1% with USD 4 Bn 2026 and is expected to reach USD 5.67 Bn in 2033. The primary drivers are defined by the rising prevalence of urinary and fecal incontinence, expanding elderly populations, increasing long-term care admissions, and growing demand for effective skin protection. According to a 2024 peer-reviewed study available through the U.S. National Institutes of Health, urinary incontinence affects approximately 25%–45% of women and 11%–34% of men worldwide. This is strengthening demand for wipes, barrier creams, cleansers, moisturizers, and protective formulations across hospitals, nursing homes, rehabilitation centers, assisted-living facilities, outpatient clinics, and home healthcare services for dependent patients.
On the basis of product type, the wipes segment is projected to account for the largest Incontinence Skin Care Products Market share of 38.5% in 2026. The segment’s growth is owing to the rapid, waterless cleansing, portability, caregiver convenience, and ability to reduce prolonged contact between fragile perineal skin and urine or feces.
CDC/NCHS survey data show that 43.8% of noninstitutionalized Americans aged 65 years and older reported urinary leakage, creating a substantial recurring need for gentle cleansing products.
In April 2026, WaterWipes expanded its personal care portfolio by launching Feminine and Incontinence Care Wipes made with over 99% water and minimal ingredients. The incontinence range offers three extra-large, pH-friendly options supporting cleansing, odor control, hydration, and skin-barrier protection.

To learn more about this report, Request Free Sample
On the basis of distribution channel, the supermarkets segment lead with a major 31.2% share in 2026. The growth is owing to the access, discreet self-selection, competitive pricing, promotions, and convenient purchase of wipes, cleansers, barrier creams, and moisturizers alongside absorbent products.
The CDC estimates urinary incontinence affects 15%–30% of people aged 60 years and older in the U.S., supporting recurring demand for products that protect skin from prolonged urine exposure. NHS England also reports that more than 14 million people in the U.K. experience bladder problems, thereby indicating a large consumer base requiring hygiene and skin-barrier care.
Urinary and fecal incontinence expose the perineal skin to moisture, digestive enzymes, changes in skin pH, and repeated friction during cleansing. Prolonged or repeated exposure can weaken the skin barrier and contribute to inflammation, redness, erosion, pain, and incontinence-associated dermatitis. Consequently, continence management increasingly includes products that cleanse gently, moisturize dry or fragile skin, and form a protective barrier against subsequent exposure.
Fecal incontinence creates an especially high risk of skin damage because stool contains digestive enzymes and microorganisms. A global systematic review covering 548,316 community-dwelling adults estimated pooled fecal-incontinence prevalence at 8.0%. Prevalence was 9.3% among people aged 60 years and above, compared with 4.9% among younger adults.
The United Nations reports that the population aged 60 years and above increased to approximately 1.2 billion in 2025 and is projected to reach 2.1 billion by 2050. WHO also identifies urinary incontinence as one of the complex geriatric syndromes that becomes more common with aging. The combination of population aging and continence-related functional dependence is expected to increase recurring consumption of wipes, wash creams, no-rinse cleansers, barrier creams, protective sprays, and barrier films across hospitals, care homes, and home-care environments.
Germany is an important market for incontinence skin care because of its aging population, organized pharmacy and medical-supply channels, developed residential-care sector, and presence of established continence-care manufacturers. Product innovation is focused on simplifying skin care for users and caregivers by combining cleansing, moisturization, and barrier protection in one product.
In 2025, HARTMANN relaunched its MoliCare SKIN 3-in-1 wet wipes for adults. The product is designed for sensitive and incontinence-stressed skin and is positioned as a water-free solution for use at home, during travel, and in professional care settings. Each wipe performs three functions of cleansing contaminants, moisturizing the skin, and depositing a protective layer.
The formulation contains 3% dimethicone, which forms a breathable protective barrier. It also includes amino acids, sweet almond oil, and essential fatty acids for skin conditioning. The wipes are pH-balanced to support the skin’s natural barrier and minimize irritation.
|
Current Event |
Description and its Impact |
|
FDA implementation of MoCRA registration requirements |
|
|
FY 2026 Medicare Skilled Nursing Facility Payment Update in the U.S. |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Request Free Sample
The North America region accounts for 37.4% of the market share in 2026. The region’s growth is owing to the large incontinence-affected population, extensive long-term-care infrastructure, and routine use of barrier creams, no-rinse cleansers, protective wipes, and moisturizers to limit urine- and feces-related skin damage.
In the United States, NIDDK reports that about 54% of women aged 20 years and older experienced urinary incontinence during the previous 12 months, indicating a substantial recurring need for preventive perineal skin care.
A notable 2026 product-development initiative began at the University of Alberta in May. A recruiting randomized study is evaluating whether a 0.5% beta-glucan moisturizing cream added to standard cleansing and barrier protection can improve healing, discomfort, safety, and tolerability in adults with incontinence-associated dermatitis during hospital care.
Asia Pacific is expected to witness strong growth in market over the forecast period. The region’s growth is owing to the expanding elderly population, rising institutional care needs, and focus on preventing incontinence-associated dermatitis (IAD).
Japan had 36.24 million people aged 65 years and above in 2024, representing 29.3% of its population, indicating a user base requiring continence and perineal skin care. Australia’s Department of Health reports that 6%–23% of residential aged-care recipients experience IAD, supporting demand for barrier creams, skin cleansers, wipes, and no-rinse formulations.
In Canada, the Incontinence Skin Care Products Market is influenced by the country’s ageing population and sustained need for moisture-associated skin damage prevention. Health Canada and the Public Health Agency of Canada estimate that more than one in five Canadian seniors experiences bladder-control problems, thereby supporting the demand for gentle cleansers, barrier creams, protective ointments, and wipes.
In June 2026, ClinicalTrials.gov updated Scotiaderm’s randomized study evaluating Dermategrity Everyday Barrier Cream against standard zinc oxide for fecal incontinence-associated skin damage. The 40-patient trial will assess healing, erythema, symptoms, safety, and satisfaction over 14 days in an ambulatory population.
China’s Incontinence Skin Care Products Market is expanding as population ageing increases people requiring continence management and protection against moisture-associated skin damage. China’s National Bureau of Statistics reported 223.09 million people aged 65 years or older in 2025, representing 15.87% of the population, supporting demand for barrier creams, cleansers, wipes, and protective films.
In December 2025, the Chinese Clinical Trial Registry recorded the launch of a Shanghai Pudong New Area Gongli Hospital study evaluating the clinical effectiveness and cost-effectiveness of a skin protectant for elderly patients with mild incontinence-associated dermatitis. This highlights institutional focus on evidence-based product selection and skin-integrity outcomes.
Some of the major key players in Incontinence Skin Care Products Market are Abena Group, Svenska Cellulosa AB, Attends Ltd, ConvaTec Group Plc., Coloplast A/S, Emilia Personal Care, Medline Industries Inc., and Coloplast.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.1% | 2033 Value Projection: | USD 5.67 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abena Group, Svenska Cellulosa AB, Attends Ltd, ConvaTec Group Plc., Coloplast A/S, Emilia Personal Care, Medline Industries Inc., and Coloplast. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Sakshi Suryawanshi is a Research Consultant with 6 years of extensive experience in market research and consulting. She is proficient in market estimation, competitive analysis, and patent analysis. Sakshi excels in identifying market trends and evaluating competitive landscapes to provide actionable insights that drive strategic decision-making. Her expertise helps businesses navigate complex market dynamics and achieve their objectives effectively.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients